Aetna PT Raised to $80.00 (AET)
Stock analysts at Barclays raised their price target on shares of Aetna (NYSE:AET) from $75.00 to $80.00 in a report issued on Wednesday, American Banking and Market News reports. The firm currently has an “overweight” rating on the stock. Barclays’ price objective would indicate a potential upside of 16.89% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at FBR Capital Markets raised their price target on shares of Aetna from $71.00 to $75.00 in a research note to investors on Friday, December 13th. They now have an “outperform” rating on the stock. Separately, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Aetna in a research note to investors on Friday, December 13th. They now have a $83.00 price target on the stock. Finally, analysts at Zacks downgraded shares of Aetna from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, November 27th. They now have a $72.00 price target on the stock. Six research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $73.33.
In other Aetna news, CEO Mark Bertolini sold 130,272 shares of the company’s stock on the open market in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $68.08, for a total transaction of $8,868,917.76. Following the transaction, the chief executive officer now directly owns 526,938 shares in the company, valued at approximately $35,873,939. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of Aetna (NYSE:AET) traded up 0.81% during mid-day trading on Wednesday, hitting $68.995. 2,046,032 shares of the company’s stock traded hands. Aetna has a 52 week low of $44.54 and a 52 week high of $69.47. The stock’s 50-day moving average is $67.13 and its 200-day moving average is $64.71. The company has a market cap of $25.356 billion and a price-to-earnings ratio of 13.84.
Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $1.53 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.53. The company had revenue of $12.99 billion for the quarter, compared to the consensus estimate of $12.89 billion. During the same quarter in the previous year, the company posted $1.55 earnings per share. The company’s revenue for the quarter was up 46.0% on a year-over-year basis. Analysts expect that Aetna will post $5.87 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Shareholders of record on Thursday, January 16th will be given a dividend of 0.225 per share. This represents a $0.90 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from Aetna’s previous quarterly dividend of $0.20.
Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.